Anfield Capital Management LLC Purchases 91 Shares of STERIS plc (NYSE:STE)

Anfield Capital Management LLC increased its position in shares of STERIS plc (NYSE:STE) by 100.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 182 shares of the medical equipment provider’s stock after buying an additional 91 shares during the period. Anfield Capital Management LLC’s holdings in STERIS were worth $37,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Ashton Thomas Securities LLC purchased a new position in STERIS during the 3rd quarter valued at about $25,000. Human Investing LLC bought a new position in shares of STERIS during the fourth quarter valued at approximately $31,000. Central Pacific Bank Trust Division increased its holdings in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares during the period. Manchester Capital Management LLC raised its stake in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 137 shares in the last quarter. Finally, Quarry LP purchased a new stake in STERIS during the third quarter worth $67,000. 94.69% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on STE. JMP Securities restated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Piper Sandler raised their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, Stephens reiterated an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Price Performance

Shares of STE stock opened at $219.23 on Friday. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a market capitalization of $21.54 billion, a price-to-earnings ratio of 46.54 and a beta of 0.84. The stock’s 50-day simple moving average is $214.76 and its 200-day simple moving average is $223.11.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be paid a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.04%. STERIS’s payout ratio is presently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.